| Literature DB >> 27957499 |
Chun San Tai1, Yi Yun Chen2, Wen Liang Chen3.
Abstract
β-Lactoglobulin (LG) is suspected to enhance or modulate human immune responses. Moreover, LG is also hypothesized to increase human cell proliferation. However, these potential functions of LG have not been directly or thoroughly addressed. In this study, we demonstrated that LG is a potent stimulator of cell proliferation using a hybridoma cell (a splenocyte fused with a myeloma cell) model. LG's ability to promote cell proliferation was lost when the protein is denatured. To further investigate the influence of LG's conformation on cell proliferation, we chemically modified LG by either carboxymethylation (CM) or acetylation and observed significantly reduced cell proliferation when the protein structure was altered. Furthermore, we proved that LG enhances cell proliferation via receptor-mediated membrane IgM receptor. These data indicated that nondenatured LG is the major component in milk that modulates cell proliferation. Collectively, our study showed that LG plays a key role in enhancing immune responses by promoting cell proliferation through IgM receptor.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27957499 PMCID: PMC5124466 DOI: 10.1155/2016/7123587
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1LG regulates cell proliferation. (a) Hybridoma cells were treated with different doses of LG for 72 hours. The MTT assay revealed that LG could stimulate cell proliferation in a dose-dependent manner. However, LG at a dose of 5 mg/mL achieved the maximal effect (OD at 540 nm = 0.6 ± 0.023). (b) Hybridoma cells were treated with different doses of whole or LG-depleted milk for 72 hours. Cell proliferation was significantly decreased by the LG-depleted milk treatment when compared with the whole milk treatment ( p < 0.001, two-tailed Student's t-test). Each experiment was performed in triplicate.
Figure 2Effect of conformationally altered LG on cell proliferation. (a) Hybridoma cells were treated with different doses (0, 0.0625, 0.125, 0.25, 0.5, and 1 mg/mL) of LG, heated LG (HLG), and BSA (as baseline treatment for comparison), respectively, for 72 hours and cell proliferation was evaluated using the MTT assay (OD at 540 nm). Each experiment was performed in triplicate. When compared to the HLG and BSA treated cells, cell proliferation was remarkably induced by LG treatments of various doses (from 0.0625 to 1 mg/mL, p < 0.001 for each dose). The data from the MTT assay are shown in table. Note: p value < 0.001 using a one-way ANOVA test. (b) To assess the effect of LG's conformation on its ability to stimulate cell proliferation, hybridoma cells were treated with normal LG (1 mg/mL), thermally denatured LG (HLG) (1 mg/mL), acetylated LG (1 mg/mL), and carboxymethylated LG (CM-LG) (1 mg/mL) for 72 hours. The MTT assay showed that only normal LG could significantly promote cell proliferation, whereas thermally denatured or chemically modified LGs had no such effect when compared to the BSA baseline treatment. (OD at 540 nm: 0.104 ± 0.008, 0.172 ± 0.035, 0.085 ± 0.002, 0.104 ± 0.005, and 0.552 ± 0.035 for BSA, acetyl LG, CM-LG, HLG, and normal LG, resp.; normal LG compared to BSA, acetyl LG, CM-LG, and HLG, p < 0.0001).
Figure 3LG is transported into the cell cytoplasm after membranous LG-LG receptor binding process. (a) Immunofluorescence analysis by confocal microscopy (magnification = 1000x): FITC-LG (1 mg) was bound to cell membranes (green colored fluorescence) at 4°C after a 30 min incubation. (b) Flow cytometry: the cells were incubated with various doses of FITC-LG (0, 0.0625 mg, 0.125 mg, 0.25 mg, and 0.5 mg) at 37°C for 30 min and then their fluorescence intensities were assessed by flow cytometry. The results showed that, as the treatment dose increased, the fluorescence intensity detected in cells obviously increased (the peak shifts to the right or a higher intensity). (c) Immunofluorescence analysis by confocal microscopy: hybridoma cells were incubated using the following conditions: (1) negative control: no green fluorescence was observed in the cell membrane or the cytoplasm; (2) cells incubated with FITC-LG at 4°C for 30 min; green fluorescence was only observed on the cell membranes; (3) cells incubated with FITC-LG at 37°C for 5 min followed by an incubation at 4°C for 25 min: green fluorescence was observed in both the cell membrane and the cytoplasm; (4) cells incubated with FITC-LG at 37°C for 30 min: green fluorescence was observed mostly in the cytoplasm. (d) Flow cytometry further confirmed these results. The data indicated that FITC-LG could be transported into the cytoplasm after binding the cell membrane.
Figure 4Purification of the LG receptor. (a) SDS-PAGE: lane I: protein ladder, lane II: LG receptor, and lane III: LG receptor with a reducing agent (β-ME); (b) Western blot. The receptor was purified using a LG affinity column. Samples from the column were analyzed by SDS-PAGE and Western blot analysis. A protein (later confirmed as the LG receptor) with a molecular weight of approximately 150 kDa was detected using a specific antibody. (c) Hybridoma cells were incubated with (1) IgG (1 mg) purified from normal rabbit serum (control) or (2) rabbit polyclonal antibodies specific to the LG receptor (1 mg). After labeling these two antibodies with FITC, the FITC-conjugated antibodies were incubated with the cells at 4°C for 30 min. We analyzed the localization of the FITC-labeled proteins using confocal microscopy (magnification = 1000x). Only rabbit polyclonal antibodies specific to the LG receptor (2) were detected on the cell membrane (green colored fluorescence). These data further confirmed that LG receptors were located on the surface of the membrane.
Figure 5Effect of anti-IgM antibody on cell proliferation using competition assay. (a) Immunofluorescence analysis (magnification = 200x): various doses of anti-IgM (0, 10, and 100 μg/mL) were added to samples containing 100 μg/mL of FITC-labeled or unlabeled LG. We observed that anti-IgM antibody could compete with FITC-labeled LG for binding on the cell surface receptor; (b) MTT assay: samples from the receptor binding competition assay, LG progressively lost its ability to stimulate cell proliferation in a dose-dependent manner ( p < 0.001).